杭州九源基因生物医药股份有限公司（02566）于2026年2月9日公布翌日披露报表，披露当日回购60,800股H股股份，约占回购前已发行股本的0.05758%。本次回购每股价格在每股港币9.81元至10元区间，总额约港币60.59万元。
回购完成后，公司已发行股份（不含库存股）总数为105,534,185股，库存股数升至3,562,600股，合计股本维持109,096,785股。据公告显示，本次回购基于2025年6月11日通过的回购授权进行，公司目前可回购股份总数为10,909,678股，截至公告日已回购3,562,600股。
公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律规定。公告由联席公司秘书黄秀签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.